Other News To Note
Monday, February 4, 2013
Antabio, of Lebege, France, said it received a €4.7 million (US$6.4 million) Wellcome Trust Seeding Drug Discovery Award to develop small-molecule drugs for the treatment of life-threatening infections caused by multidrug-resistant Gram-negative bacteria.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.